2013
DOI: 10.1007/s10529-013-1349-5
|View full text |Cite
|
Sign up to set email alerts
|

Low temperature cell pausing: an alternative short-term preservation method for use in cell therapies including stem cell applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
5
3
1

Relationship

2
7

Authors

Journals

citations
Cited by 32 publications
(17 citation statements)
references
References 42 publications
0
16
0
Order By: Relevance
“…There is a wealth of information and large range of protocols available regarding the preservation of cells, including stem cells (the reader is directed to a number of recent reviews: Coopman, 2011;Golab et al, 2013;Hunt, 2011;Robinson et al, 2014;Thirumala et al, 2013). A recent overview of proposals submitted to the FDA for MSCbased products indicated that >80% of 66 submissions considered used cryopreservation to store and transport their product (Mendicino et al, 2014).…”
Section: Can the Cell Therapy Be Preserved And If So How?mentioning
confidence: 99%
See 1 more Smart Citation
“…There is a wealth of information and large range of protocols available regarding the preservation of cells, including stem cells (the reader is directed to a number of recent reviews: Coopman, 2011;Golab et al, 2013;Hunt, 2011;Robinson et al, 2014;Thirumala et al, 2013). A recent overview of proposals submitted to the FDA for MSCbased products indicated that >80% of 66 submissions considered used cryopreservation to store and transport their product (Mendicino et al, 2014).…”
Section: Can the Cell Therapy Be Preserved And If So How?mentioning
confidence: 99%
“…• C or ambient temperatures, remains limited (Robinson et al, 2014). In particular, despite the fact that cells for cell therapy will more than likely be stored in suspension, most research is focused on how cells adhered to a surface respond to hypothermic conditions, limiting the relevance of these studies.…”
Section: Can the Cell Therapy Be Preserved And If So How?mentioning
confidence: 99%
“…The adhesion ability was poor and CFU capacity was low (8.67 ± 1.67). High level of late stage apoptosis, poor adhesion ability and low CFU capacity showed that cells could not adequately be stored for 48 h. These results may be a consequence of reduced nutrient supply and increase in waste and lactic acid accumulation during prolonged storage (Robinson, Picken & Coopman, 2014). The late stage apoptosis of cells (29.13 ± 3.22%) stored for 24 h was acceptable, and the CFU number (17.07 ± 4.01) of cells stored for 24 h was relatively high.…”
Section: Discussionmentioning
confidence: 99%
“…This includes hypothermic preservation (i.e. 'cell pausing') at either ambient [5][6][7] or refrigerated chilled temperatures [8,9]. Ultimately, the decision as to which biopreservation method is most appropriate will need to take into account which method has the least effect on the product's CQAs whilst remaining both commercially, clinically and logistically viable.…”
Section: Types Of Biopreservationmentioning
confidence: 99%